c-MYC anticorps
MYC
Reactivité: Humain
WB
Hôte: Lapin
Polyclonal
unconjugated
N° du produit ABIN2147090
-
-
Antigène
Voir toutes c-MYC (MYC) Anticorps
-
c-MYC (MYC)
(Myc Proto-Oncogene protein (MYC))
-
Reactivité
-
Humain
-
Hôte
-
Lapin
-
Clonalité
-
Polyclonal
-
Conjugué
-
Cet anticorp c-MYC est non-conjugé
-
Application
-
Western Blotting (WB)
-
Purification
-
Myc antibody was purified by immunoaffinity chromatography.
-
Immunogène
-
Myc antibody was raised in Rabbit using the peptide sequence around aa 371~375 (K-R-S-F-F) derived from Human Myc as the immunogen.
-
Top Product
-
Discover our top product MYC Anticorps primaire
-
-
-
Indications d'application
-
WB: 1:500-1:1000
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Concentration
-
Lot specific
-
Buffer
-
In liquid form PBS buffer (no MG2+ or Ca2+), pH 7.4, 150 mm NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
-
Sodium azide
-
Précaution d'utilisation
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles
-
Stock
-
-20 °C
-
Stockage commentaire
-
Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
Antigène
-
c-MYC (MYC)
(Myc Proto-Oncogene protein (MYC))
-
Autre désignation
-
Myc (MYC Produits)
-
Synonymes
-
anticorps MRTL, anticorps MYCC, anticorps bHLHe39, anticorps c-Myc, anticorps CMYC, anticorps c-myc, anticorps C-MYC, anticorps LOC100136746, anticorps ARC, anticorps B430311C09Rik, anticorps MYC, anticorps NOP, anticorps Nop30, anticorps RNCMYC, anticorps mMyc, anticorps AU016757, anticorps Myc2, anticorps Niard, anticorps Nird, anticorps cmyc, anticorps zc-myc, anticorps c-myc II, anticorps myc-B, anticorps myc2, anticorps myc1, anticorps CMyc, anticorps zgc:55680, anticorps CG10798, anticorps D-Myc, anticorps DM, anticorps DMYc, anticorps Dm, anticorps Dmel\CG10798, anticorps Dmyc, anticorps EG:BACN5I9.1, anticorps anon-WO03040301.171, anticorps bHLHe57, anticorps c-MYC, anticorps d-myc, anticorps dMYC, anticorps dMyc, anticorps dMyc1, anticorps da, anticorps dm, anticorps dm/dMyc, anticorps dm/myc, anticorps dmyc, anticorps dmyc1, anticorps l(1)G0139, anticorps l(1)G0354, anticorps l(1)G0359, anticorps myc, anticorps MYC proto-oncogene, bHLH transcription factor, anticorps v-myc myelocytomatosis viral oncogene homolog, anticorps nucleolar protein 3 (apoptosis repressor with CARD domain), anticorps myelocytomatosis oncogene, anticorps MYC proto-oncogene, bHLH transcription factor a, anticorps MYC proto-oncogene, bHLH transcription factor L homeolog, anticorps MYC proto-oncogene, bHLH transcription factor S homeolog, anticorps v-myc myelocytomatosis viral oncogene homolog (avian), anticorps MYC proto-oncogene, bHLH transcription factor b, anticorps CG10798 gene product from transcript CG10798-RB, anticorps MYC, anticorps LOC100136746, anticorps Nol3, anticorps Myc, anticorps myca, anticorps myc.L, anticorps myc.S, anticorps mycb
-
Pathways
-
Signalisation p53, Cycle Cellulaire, Sensory Perception of Sound, Transition Metal Ion Homeostasis, Mitotic G1-G1/S Phases, Positive Regulation of Endopeptidase Activity, Regulation of Carbohydrate Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus, L'effet Warburg
-